Brief: Qlife Says Hipro To Accelerate Egoo Development, Regulatory Approval In China

Qlife Holding AB

13/03/2026 07:34

March 13 (Reuters) - Qlife Holding AB QLIFE.ST:

HIPRO TO ACCELERATE EGOO DEVELOPMENT AND REGULATORY APPROVAL IN CHINA FOLLOWING STRONG INTEREST

HIPRO WILL MANAGE PRODUCT DEVELOPMENT ACTIVITIES, REGULATORY SUBMISSIONS, MANUFACTURING, AND COMMERCIALIZATION IN CHINESE MARKET.

QLIFE WILL RECEIVE A ROYALTY OF 20 PERCENT ON NET SALES GENERATED FROM EGOO IN CHINA

Source text: ID:nWkr7r4V7r

Further company coverage: QLIFE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))